GSK962040
Drug timelines are a Plus or Pro feature.
9 regulatory and trial events tracked for GSK962040, covering 2017-01-30 to 2017-10-13. Get the full timeline:
Most recent: Clinical Trial Update: Dose Response of 28 Days of Dosing of GSK962040 in Type I and II Diabetic Male and Female Subjects With Gastroparesis [Phase 2]